Trinity Stack
- Category
- Aesthetic & Beauty
- Purpose
- Regenerative Aesthetics, Metabolic Support & Cellular Repair
- Peptides
- GHK-CuNAD+BPC-157Tesamorelin
Research basis
Tesamorelin is FDA-approved (for HIV-associated lipodystrophy); GHK-Cu is an approved cosmetic ingredient; NAD+ and BPC-157 remain research compounds. No published clinical trial has evaluated this four-peptide combination together — the stack is a research-community grouping, not a studied protocol.
⚠️ This page describes a combination of compounds that are, with few exceptions, not approved by the FDA for any use. It records protocols described in research and community sources. It is not a recommendation, not a prescription, and not medical advice. Combining compounds multiplies the unknowns rather than adding them. Do not act on anything here without a qualified healthcare professional who knows your history.